Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs DAR✓SelectedUSD · DARGSK vs DAR performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs DAR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
DAR return
-31.1%
Excess return
+77.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioDARExcessAlpha
1D-0.1%-4.1%+4.1%+0.1%
7D-1.3%+2.2%-3.5%-1.4%
30D+2.7%-12.5%+15.3%+3.3%
3M+2.7%-19.9%+22.7%+3.7%
6M+3.3%-13.9%+17.3%+3.8%
YTD+6.5%+49.1%-42.6%+3.1%
1Y+10.7%+54.4%-43.8%+6.9%
3Y+64.4%+29.1%+35.2%+58.4%
5Y+46.7%-29.2%+75.9%+49.3%
All+46.7%-31.1%+77.8%+49.3%

Cumulative growth

Daily Returns

Daily percentage return beside DAR.

Daily Out/Under-Performance

Portfolio return minus DAR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × DAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded DAR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling